Cormorant Asset Management, LP - RAIN THERAPEUTICS INC ownership

RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 62 filers reported holding RAIN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.70 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of RAIN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$26,033
+9.2%
2,978,6600.0%1.71%
+7.5%
Q4 2022$23,829
-99.8%
2,978,660
+28.0%
1.60%
+100.9%
Q3 2022$11,354,000
-12.2%
2,326,6600.0%0.79%
-18.8%
Q2 2022$12,936,000
+9.7%
2,326,6600.0%0.98%
+7.9%
Q1 2022$11,796,000
-60.6%
2,326,6600.0%0.91%
-49.2%
Q4 2021$29,967,000
-13.9%
2,326,6600.0%1.78%
+26.0%
Q3 2021$34,807,000
-12.4%
2,326,660
-11.4%
1.41%
+4.7%
Q2 2021$39,734,0002,626,6601.35%
Other shareholders
RAIN THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 1,637,308$25,444,0003.14%
Cormorant Asset Management, LP 2,626,660$39,734,0001.35%
BVF INC/IL 1,945,949$30,240,0001.13%
Logos Global Management LP 780,331$12,126,0001.02%
ACUTA CAPITAL PARTNERS, LLC 162,245$2,521,0001.01%
LUMINUS MANAGEMENT LLC 425,000$6,605,0000.96%
Boxer Capital, LLC 1,175,000$18,260,0000.64%
Perceptive Advisors 5,074,038$78,850,0000.51%
Lumina Fund Management LLC 6,000$93,0000.04%
Monashee Investment Management LLC 20,000$311,0000.04%
View complete list of RAIN THERAPEUTICS INC shareholders